The Life Science Market will witness a CAGR of 4%, reaching US$ 4,200 Million between 2024. With medical IoT implying the use of wearable monitors, devices, and various integrated applications regarding healthcare needs, the healthcare vertical is bound to scale new-fangled heights in the upcoming period. This is what the healthcare vertical would all be in the next 10 years.
According to a study conducted by Persistence Market Research (PMR) on the global market for life science products, incessant progress in the field of biotech science has led to the development of various new-age and consumer-friendly life science products in recent years. The PMR study reveals that the global life science products market is set to witness a CAGR of over 4% in terms of revenue between 2016 -2024. The market is expected to create an absolute $ opportunity of US$ 114.9 Million in 2017 over 2016.
Availability of advanced technological support and a continuously expanding information database owing to intensive analysis and combined research expeditions on various life science topics has resulted in the development of novel therapeutics. Accordingly, the arrival of latest antibody manufacturing methods has greatly improved the overall propositions of scientific research and analysis activities.
Planning Forward? Access Sample Of Life Science Market Report! https://www.persistencemarketresearch.co/samples/9986
- Abcam Plc
- A.M.S. Biotechnology (Europe) Limited
- Bio-Rad Laboratories Inc.
- BPS Bioscience Inc.
- Crown Bioscience Inc.
- Genscript Biotech Corporation
- Merck Millipore Limited
- PerkinElmer Inc.
- Sigma Aldrich Corp.
- Thermo Fisher Scientific Inc.
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Life Science Market? https://www.persistencemarketresearch.co/methodology/9986
Likewise, the emergence of academia as the primary organization for conducting basic research is expected to accelerate the growth of the life science products market.
PMR indicates that low reproducibility of research and poor specificity of products coupled with high cost of technology restricting robust adoption are the major impediments of the market. Further, lengthy lead durations for custom research requirements may also inhibit the overall market growth.
Based on product type, demand for antibodies is expected to remain high during the forecasted period. In 2015, the antibodies segment accounted for nearly 83% share of the market in terms value. This is primarily due to higher investment in R&D pipelines, especially in the region of Asia Pacific. The antibodies segment is followed by recombinant proteins segment, which is projected to surpass a market valuation of over US$ 470 Million by 2024-end.
On the basis of application, basic research is the predominant segment of the market estimated to reach a market valuation of US$ 2,600.5 million by the end of the assessment period. Whereas, the drug discovery and development segment is projected to witness the highest growth rate, reflecting a CAGR of 4.7% over the period of forecast.
Planning To Introduce An Offbeat Product/Technology In The Life Science Market? Go To “Purchase Now” To Have Our Life Science Market Report! https://www.persistencemarketresearch.com/checkout/9986
In addition, the current market valuation of drug discovery & development is US$ 350.5 Million, which is estimated to surpass US$ 506 Million by the end of 2024.
Based on end-user, academic and research institutes is the leading segment of the market. In 2015 the segment accounted for over 42% share of the market in 2015. In terms of growth, contract research organizations is anticipated to be the fastest growing segment, registering 5.3% CAGR over the assessment period.
In 2016, the life science products market in Asia Pacific accounted for the maximum share in terms of value. The region is set to ride on a strong CAGR of over 5% during the evaluation period. Higher public and private R&D initiatives on life science research are lifting up the biotechnology and pharmaceuticals sector in Asia to a significant extent. This, in turn, is stimulating the market growth in the region.
Access Trending Reports:
Home Infusion Therapy Market – The global home infusion therapy devices market was valued at US$ 15,905.1 Mn in 2014 and is expected to grow at a CAGR of 9% from 2014 to 2020, to reach US$ 26,747.8 Mn by 2020.
Digital Intraoral Sensors And Consumables Market – In terms of revenue, the global digital intraoral sensors and consumables market is expected to grow at a promising CAGR of 5.0% over the next decade.
Attention Deficit Hyperactivity Disorder Therapeutics Market – The global attention-deficit hyperactivity disorder (ADHD) therapeutics market was valued at US$ 19 Bn in 2020, and is expected to witness a CAGR of 7% during the forecast period (2020–2030).
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com
Persistence Market Research Address – 305 Broadway, 7th Floor, New York City, NY 10007, United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353